期刊文献+

^(14)C-缬氨酸在实验性大鼠肝性脑病脑组织中的示踪观察 被引量:2

(14)C-valine Trace in Brain Tissue of Experiment Rats with Hepatic Encephalopathy
下载PDF
导出
摘要 应用放射自显影技术,观察经颈总动脉快速注射示踪剂后大鼠急性肝功能衰竭(AHF)所致肝性脑病(HE)的脑组织对(14)C-缬氨酸的摄取情况,并电镜观察其血脑屏障(BBB)改变。结果发现,HE大鼠脑组织对(14)C-缬氨酸的摄入量较正常大鼠增多(p<0.05)。电镜下可见神经胶质细胞和毛细血管内皮细胞胞浆中囊泡增多.说明大鼠8B8对(14)C-缬湖氨酸的通透性增加。实验性HE大鼠BBB结构和功能均有改变。本研究提示:临床上经静脉输入高浓度支链氨基酸(BCAA)治疗AHF引起的HE可以促使脑组织BCAA浓度增加。 ranch-chain aminoacid is often given through intravenation or oral administration in the clinicaltreatment of hepatic encephalopathy due to acute hepatic failure. We observed the uptake of(14)C-valinein brain tissue of rats with hepatic encephalopathy due to acute hepatic failure,Autoradiography tech-nique was used after rapid injection of the drug into the rat common carotid artery.We observed thechanges of blood-brain barrier with electron microscope;The results showed that the uptake of(14)C-va-line in brain tessue of rats with hepatic encephalopathy was more than that of the control.Under elec-tron microscope astroglia and capillary endothelial cell showed increased vesicles. Our results indicatedthe permeability of(14)C-valine was increased in blood-brain barrier of rats with hepatic encephalopathy. Both the structure and function of blood-brain barrier in rats with hepatic encephalopathy had changed.Our study suggested that in the treatment of hepatic encepalopathy due to acute hepatic failure intrave-nation of branch-chain aminoacid of high concentration might increase the concentration of branch-chainaminoacid in brain tissue.
出处 《中国医科大学学报》 CAS CSCD 1996年第3期279-281,284,共4页 Journal of China Medical University
关键词 肝性脑病 血脑屏障 缬氨酸 hepatic encephalopathy branch-chain aminoacid,blood brain barrier
  • 相关文献

参考文献1

  • 1夏宗勤,实验核医学与核药学,1982年

同被引文献17

  • 1刘洪艳,王静艳,雷薇,闻颖,刘沛.氨对肝硬化大鼠模型脑神经细胞凋亡的影响[J].世界华人消化杂志,2004,12(8):1865-1867. 被引量:9
  • 2朱建辉,叶诸榕,胡美玉,刁自强,李桢.氨对培养胚鼠大脑神经元形态的影响[J].中华病理学杂志,1996,25(3):139-141. 被引量:3
  • 3贾林 李瑜元 等.门体性肝性脑病的发病机制及其治疗[J].世界华人消化杂志,1999,7:716-716.
  • 4Bergqvist P. B. F, Carpenedo R, Apelqvist G, et al. Plasma and brain levels of oxindole in experimental chronic Hepatic Encephalopathy: Effects of Systemic Ammonium Acetate and L-Tryptophan[ J]. Pharmacol Toxicol, 1999;85 : 138 - 143.
  • 5渡边 正義,尾崎 孝幸,平田 佳久.實驗的肝性昏睡ぅシトモヂルにおけゐ血中おょび腦內アクチト-ル(NS-4)の作用[J].日藥理誌,1995,105:97-109.
  • 6Bergqvist PBF,Carpenede R,Apelqvist G,Moroni F,Bengtsson F.Plasma and brain levels of oxindole in experimental chzonic hepatic encephalopathy:Effects of systemic amonium acctate and L-tryptophan .Pharmacol Taxicol 1999;85:138-143.
  • 7Brensing KA,Textor J,Strunk H,Klehr HU,Schild H,Sauerbruch T.Transijugular intrahepatic portosystemic stentshunt for hepatorenal syndrome.The Lancet 1997;349:697-700.
  • 8Rose G,Michalak,A,Rao KVR,Quack G,Kircheis G,Butterworth RF.L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failur.Hepatology 1999;30:635-640.
  • 9Hetts SW,To die or not to die:An overview of qpoplosis and its rofe in disease.JAMA 1998;279:300-307.
  • 10Thompson CB,Apotosis in the pathogenesis and treatment of disease,Science 1997,267:1456-1462.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部